MAPT and Alzheimer disease: In the brain, the glymphatic system contributes to Aβ and tau clearance, and the loss of polarity of AQP4 in the endfeet of astrocytes along with its upregulation in reactive astrocytes has been largely described in AD rodent models [74, 75].